Abstract:During fetal life and the transition to extra-uterine air breathing, pulmonary vascular tone is regulated by a complex, interactive group of mechanisms. Arachidonic acid metabolites play an important role in this regulation. Although prostaglandins may not be central to regulation of the resting fetal pulmonary circulation, PGI2 acts to modulate tone and thereby maintain pulmonary vascular resistance relatively constant. PGI2 also may play an important role as one of the components involved in the major changes that occur with the onset of air breathing. Leukotrienes, also metabolites of arachidonic acid and potent smooth muscle constrictors, may play an active role in maintaining the normally high fetal pulmonary vascular resistance, because leukotriene receptor blockade or synthesis inhibition increases pulmonary blood flow about eight-fold; the presence of leukotrienes in fetal tracheal fluid further supports this. In addition to PGI2, vascular endothelial cells produce other vasoactive factors. These include potent vasodilators, such as endothelium-derived relaxing factor (EDRF). EDRF, known to be nitric oxide (NO) and often called endothelium-derived nitric oxide (EDNO), is produced by endothelial cells in response to varied stimuli, generally involving specific receptors and the activation of endothelial NO synthetase (eNOS); subsequent smooth muscle relaxation is produced by a NO/guanylyl cyclase/cGMP-mediated mechanism. NO clearly is involved in regulation of vascular tone in the fetal pulmonary circulation, although it plays a far more important role in the postnatal transition to air breathing. Superfused fetal sheep pulmonary arteries release NO when stimulated with bradykinin. In fetal lambs the vasodilating effects of bradykinin are attenuated by methylene blue and resting tone falls with N(omega)-nitro-L-arginine, an inhibitor of NO synthesis, suggesting that a NO/cGMP-dependent mechanism continuously modulates or offsets the increased tone of the resting fetal pulmonary circulation. Inhibition of NO synthesis blocks the pulmonary vasodilation with oxygenation of fetal lungs in utero. Shear stress-induced NO production as well as the relationship of oxygenation to NO production further support the important function of NO in the transition. Although endothelin-1 (ET-1) has potent vasoactivity as well as ontogenetic differences in effect on pulmonary vascular resistance, its exact physiological role has not been defined. Adrenomedullin and calcitonin gene-related peptide (CGRP), two additional vasoactive substances, have profound, and prolonged, vasodilating effects in the fetal pulmonary circulation. Their physiological roles have not yet been established.

Effect of 8-isoprostaglandin F2alpha on the newborn rat pulmonary arterial muscle and endothelium

Anti-placental Growth Factor Antibody Ameliorates Hyperoxia-Mediated Impairment of Lung Development in Neonatal Rats

Fetal Pulmonary Vascular Remodeling in A Rat Model Induced by Hypoxia and Indomethacin

The Effect of Vitamin A on Contraction of the Ductus Arteriosus in Fetal Rat

Effect of inhaled nitric oxide on aquaporin expression in newborn rat lung in acute hyperoxic lung injury

[Effect of Inhaled Nitric Oxide on Surfactant Protein A and Mannose Binding Ability in the Lung of Neonatal Rats with Hyperoxia-Induced Lung Injury].

Control of the pulmonary circulation in the fetus and during the transitional period to air breathing

Intrauterine Growth Restriction Does not Change the Regulation of Arterial Contractile Responses in Rats during Early Postnatal Period

Reactive oxygen species augment contractile responses of saphenous artery in 10-15-day-old but not adult rats: Substantial role of NADPH oxidases

The Role of Inos-Derived NO in the Antihypertrophic Actions of B-type Natriuretic Peptide in Neonatal Rat Cardiomyocytes

Effect of Isopropyl 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate on Rat Pulmonary Artery Smooth Muscle

Perinatal hypoxia augments contractile impact of NADPH oxidase-derived ROS in early postnatal rat arteries

1527 PROSTAGLANDIN D2 DOES NOT LOWER PULMONARY ARTERIAL PRESSURE OR IMPROVE OXYGENATION IN INFANTS WITH PERSISTENT PULMONARY HYPERTENSION SYNDROME (PPHN)

Effect of Progesterone on the Contractile Response of Isolated Pulmonary Artery in Rabbits

Role of Cgmp-Dependent Protein Kinase in Development of Tolerance to Nitric Oxide in Pulmonary Veins of Newborn Lambs.

Regulation of Rat Intrapulmonary Arterial Tone by Arachidonic Acid and Prostaglandin E2 During Hypoxia

Impact of nitric oxide on platelet-derived growth factor expression in intrapulmonary arteries of rats with hypoxic pulmonary vascular structural remodeling

Altered prostanoid metabolism contributes to impaired angiogenesis in persistent pulmonary hypertension in a fetal lamb model

Molecular Mechanisms Regulating the Vascular Prostacyclin Pathways and Their Adaptation during Pregnancy and in the Newborn

[Effect of platelet-derived growth factor-BB on pulmonary vascular remodeling in neonatal rats with hypoxic pulmonary hypertension and its mechanism]

Inhibition of endogenous nitric oxide synthase potentiates nitrovasodilators in experimental pulmonary hypertension